The Valley Desk

NCT00006345 · Interventional trial

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Overall registry status Completed

Phase 2

Conditions Drug/Agent Toxicity by Tissue/Organ, Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov